Yatharth Hospital & Trauma Care Services Announces Interim Dividend, Approves ESOP, and Releases Quarterly Financial Results
Yatharth Hospital & Trauma Care Services Limited announced several corporate decisions following its Board meeting held on August 10, 2026. The company released its unaudited financial results for the first quarter ended June 30, 2026 (both standalone and consolidated), declared an interim dividend, and approved a new Employee Stock Option Scheme.The Board of Directors also re-appointed a Cost Auditor for the current financial year.
Financial Performance Snapshot
Yatharth Hospital & Trauma Care Services Limited reported its unaudited financial results for the quarter ended June 30, 2026. The performance figures are presented below in millions of INR (except shares and EPS).Standalone Unaudited Financial Results (Q1 FY 2026)
| Particulars | Quarter Ended June 30, 2026 (Unaudited) | Quarter Ended March 31, 2026 (Audited) | Quarter Ended June 30, 2025 (Unaudited) | Year Ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Revenue from operations | 1,763.08 | 1,638.71 | 1,307.22 | 5,918.84 |
| Other income | 133.30 | 67.64 | 66.81 | 232.10 |
| Total Income | 1,896.38 | 1,706.35 | 1,374.03 | 6,150.94 |
| Total expenses | 1,515.53 | 1,396.21 | 999.34 | 4,879.10 |
| Profit before tax | 380.85 | 310.14 | 374.69 | 1,271.84 |
| Total tax expense | 99.17 | 72.58 | 103.47 | 317.74 |
| Profit for the period/year | 281.68 | 237.56 | 271.22 | 954.10 |
Consolidated Unaudited Financial Results (Q1 FY 2026)
| Particulars | Quarter Ended June 30, 2026 (Unaudited) | Quarter Ended March 31, 2026 (Audited) | Quarter Ended June 30, 2025 (Unaudited) | Year Ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Revenue from operations | 3,926.54 | 3,415.63 | 2,592.47 | 12,071.72 |
| Other income | 43.53 | 71.08 | 78.35 | 257.87 |
| Total Income | 3,970.07 | 3,486.71 | 2,670.82 | 12,329.59 |
| Total expenses | 3,358.02 | 2,967.19 | 2,083.94 | 10,093.99 |
| Profit/ (loss) before exceptional items and tax | 612.05 | 519.52 | 586.88 | 2,235.60 |
Key Corporate Actions and Decisions
Interim Dividend DeclarationThe Board of Directors approved and declared the first interim dividend for the Financial Year 2026-27. The dividend is set at Rs. 0.50 (Fifty Paisa) per equity share, which represents 5% of the face value of ₹10 per share. This declaration amounts to Rs. 4,81,77,178.50. The record date for members to be entitled to this interim dividend has been set as August 14, 2026.
Employee Stock Option Scheme (ESOP)
The company approved the introduction of the Yatharth Hospital & Trauma Care Services Employees Stock Option Scheme 2026 (ESOP 2026). This scheme covers a total of 250,000 Equity Shares, each with a face value of Rs. 10. The terms specify that vesting may commence after a period of not less than one year from the date of individual grant, and the exercise period shall not exceed two years from the respective vesting date.
Cost Auditor Re-appointment
M/s Subodh Kumar & Co., Cost Accountants (Firm registration number: 104250), was re-appointed as the Cost Auditor for Yatharth Hospital & Trauma Care Services Limited for the Financial Year 2026-27, effective August 10, 2026.
Company Operations
Yatharth Hospital & Trauma Care Services operates multiple hospital facilities across India. These include locations in greater Noida and Noida, Uttar Pradesh; Orchha, Madhya Pradesh; Faridabad, Haryana; and New Delhi.YATHARTH Stock Price Movement
Yatharth Hospital & Trauma Care Services Limited shares rallied today, closing at ₹898.75 after settling up 3.39% in post-market trading. The stock saw a robust performance during the day, achieving significant highs and confirming its status as a major gainer in the healthcare sector.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: